Joshua Cohen B.'s most recent trade in Amylyx Pharmaceuticals Inc was a trade of 373,295 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amylyx Pharma Inc | Joshua B. Cohen | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 373,295 | 373,295 | - | - | Stock Option (Right to Buy) | |
| Amylyx Pharma Inc | Joshua B. Cohen | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 248,865 | 3,583,548 | - | 0 | Common Stock |